Investor Presentaiton slide image

Investor Presentaiton

Company Overview About Us Biond Biologics is a private clinical-stage biopharmaceutical company, developing novel immunotherapies for cancer and a platform enabling the intracellular delivery of biologics . • Our Innovation At the forefront of research of immune-evasion mechanisms and its translation into novel cancer therapeutics Advanced in-house research capabilities and access to fresh tumor and blood samples from cancer patients A Transformative platform enabling delivery of biologics into cells, targeting intracellular "undruggable" proteins The Team • Proven track record for developing novel drug candidates from scientific concept to clinical trials • Highly experienced in fund raising - securing private and public funding Successfully partnering with large biopharma companies: . . July 2015- Merck/CCAM; CM-24 mAb, phase-1 asset (M&A, $95M upfront) ⚫ Jan 2021- Sanofi/Biond; BND- 22 mAb, IND ready asset (Licensed, $125M upfront) BIOND BIOLOGICS Biond Biologics Corporate Presentation | May 2021 | Non-confidential 2
View entire presentation